These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 14634087)

  • 1. Human ErbB-2 (Her-2) transgenic mice: a model system for testing Her-2 based vaccines.
    Piechocki MP; Ho YS; Pilon S; Wei WZ
    J Immunol; 2003 Dec; 171(11):5787-94. PubMed ID: 14634087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementary antitumor immunity induced by plasmid DNA encoding secreted and cytoplasmic human ErbB-2.
    Piechocki MP; Pilon SA; Wei WZ
    J Immunol; 2001 Sep; 167(6):3367-74. PubMed ID: 11544327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of mammary carcinoma development in HER-2/neu transgenic mice through induction of autoimmunity by xenogeneic DNA vaccination.
    Pupa SM; Iezzi M; Di Carlo E; Invernizzi A; Cavallo F; Meazza R; Comes A; Ferrini S; Musiani P; Ménard S
    Cancer Res; 2005 Feb; 65(3):1071-8. PubMed ID: 15705909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of DNA vaccines encoding self or heterologous Her-2/neu in Her-2 or neu transgenic mice.
    Jacob J; Radkevich O; Forni G; Zielinski J; Shim D; Jones RF; Wei WZ
    Cell Immunol; 2006 Apr; 240(2):96-106. PubMed ID: 16930573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination with cytoplasmic ErbB-2 DNA protects mice from mammary tumor growth without anti-ErbB-2 antibody.
    Pilon SA; Piechocki MP; Wei WZ
    J Immunol; 2001 Sep; 167(6):3201-6. PubMed ID: 11544306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA vaccination against rat her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice.
    Rovero S; Amici A; Di Carlo E; Bei R; Nanni P; Quaglino E; Porcedda P; Boggio K; Smorlesi A; Lollini PL; Landuzzi L; Colombo MP; Giovarelli M; Musiani P; Forni G
    J Immunol; 2000 Nov; 165(9):5133-42. PubMed ID: 11046045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Her-2 DNA versus cell vaccine: immunogenicity and anti-tumor activity.
    Whittington PJ; Radkevich-Brown O; Jacob JB; Jones RF; Weise AM; Wei WZ
    Cancer Immunol Immunother; 2009 May; 58(5):759-67. PubMed ID: 18836716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HER-2 DNA and protein vaccines containing potent Th cell epitopes induce distinct protective and therapeutic antitumor responses in HER-2 transgenic mice.
    Renard V; Sonderbye L; Ebbehøj K; Rasmussen PB; Gregorius K; Gottschalk T; Mouritsen S; Gautam A; Leach DR
    J Immunol; 2003 Aug; 171(3):1588-95. PubMed ID: 12874253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins.
    Quaglino E; Mastini C; Amici A; Marchini C; Iezzi M; Lanzardo S; De Giovanni C; Montani M; Lollini PL; Masucci G; Forni G; Cavallo F
    Cancer Res; 2010 Apr; 70(7):2604-12. PubMed ID: 20332241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broadening of epitope recognition during immune rejection of ErbB-2-positive tumor prevents growth of ErbB-2-negative tumor.
    Pilon SA; Kelly C; Wei WZ
    J Immunol; 2003 Feb; 170(3):1202-8. PubMed ID: 12538677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of PI3K/Akt-mediated tumorigenic signals through PTEN activation by DNA vaccine-induced anti-ErbB2 antibodies.
    Porzia A; Lanzardo S; Citti A; Cavallo F; Forni G; Santoni A; Galandrini R; Paolini R
    J Immunol; 2010 Apr; 184(8):4170-7. PubMed ID: 20220087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic regulation of the response to Her-2 DNA vaccination in human Her-2 transgenic mice.
    Radkevich-Brown O; Jacob J; Kershaw M; Wei WZ
    Cancer Res; 2009 Jan; 69(1):212-8. PubMed ID: 19118005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo electroporation restores the low effectiveness of DNA vaccination against HER-2/neu in aging.
    Provinciali M; Barucca A; Pierpaoli E; Orlando F; Pierpaoli S; Smorlesi A
    Cancer Immunol Immunother; 2012 Mar; 61(3):363-71. PubMed ID: 21922332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCL21 (SLC) improves tumor protection by a DNA vaccine in a Her2/neu mouse tumor model.
    Nguyen-Hoai T; Baldenhofer G; Sayed Ahmed MS; Pham-Duc M; Vu MD; Lipp M; Dörken B; Pezzutto A; Westermann J
    Cancer Gene Ther; 2012 Jan; 19(1):69-76. PubMed ID: 21997231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HER-2/neu is a tumor rejection target in tolerized HER-2/neu transgenic mice.
    Reilly RT; Gottlieb MB; Ercolini AM; Machiels JP; Kane CE; Okoye FI; Muller WJ; Dixon KH; Jaffee EM
    Cancer Res; 2000 Jul; 60(13):3569-76. PubMed ID: 10910070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA immunization using constant-current electroporation affords long-term protection from autochthonous mammary carcinomas in cancer-prone transgenic mice.
    Curcio C; Khan AS; Amici A; Spadaro M; Quaglino E; Cavallo F; Forni G; Draghia-Akli R
    Cancer Gene Ther; 2008 Feb; 15(2):108-14. PubMed ID: 17992201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The collaboration of both humoral and cellular HER-2/neu-targeted immune responses is required for the complete eradication of HER-2/neu-expressing tumors.
    Reilly RT; Machiels JP; Emens LA; Ercolini AM; Okoye FI; Lei RY; Weintraub D; Jaffee EM
    Cancer Res; 2001 Feb; 61(3):880-3. PubMed ID: 11221874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA vaccines encoding full-length or truncated Neu induce protective immunity against Neu-expressing mammary tumors.
    Chen Y; Hu D; Eling DJ; Robbins J; Kipps TJ
    Cancer Res; 1998 May; 58(9):1965-71. PubMed ID: 9581840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice.
    Quaglino E; Iezzi M; Mastini C; Amici A; Pericle F; Di Carlo E; Pupa SM; De Giovanni C; Spadaro M; Curcio C; Lollini PL; Musiani P; Forni G; Cavallo F
    Cancer Res; 2004 Apr; 64(8):2858-64. PubMed ID: 15087404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HSP110-HER2/neu chaperone complex vaccine induces protective immunity against spontaneous mammary tumors in HER-2/neu transgenic mice.
    Manjili MH; Wang XY; Chen X; Martin T; Repasky EA; Henderson R; Subjeck JR
    J Immunol; 2003 Oct; 171(8):4054-61. PubMed ID: 14530326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.